石藥集團(01093.HK):與石藥控股簽訂新租賃協議
格隆匯6月24日丨石藥集團(01093.HK)公佈,舊租賃協議已於2022年6月24日屆滿。於2022年6月24日,(a)河北兒童醫院(作為承租人)與石藥控股(作為業主)就物業1訂立一份新租賃協議;(b)石藥歐意(作為承租人)與石藥控股(作為業主)就物業2、3及4訂立一份新租賃協議;及(c)石藥中諾(作為承租人)與石藥控股(作為業主)就物業5及6訂立一份新租賃協議,全部由2022年6月25日起計為期三年,並於2025年6月24日屆滿。
訂立新租賃協議旨在確保使用該等物業,以維持集團於石家莊的營運暢順及不受干擾,包括集團擁有的兒童醫院及集團生產設施的營運,以及集團於石家莊的辦公室及員工宿舍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.